Skip to main content
Live · TradingView
Back to the NewsWire

Investingnews

Published September 22, 2026

Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer | INN

Read the full story at Investingnews

Optimi Health Corp. a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the appointment of.

Surfaced by 3 Google Alerts

  • Psychedelics
  • MDMA
  • Psychedelic press release